Categories

Amunix Operating Inc. – Product Pipeline Review – 2015

US$ 1500

This report provides comprehensive information on the current therapeutic developmental pipeline of Amunix Operating Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

06-23 2015   Pages: 37

Regeneron Pharmaceuticals, Inc. – Product Pipeline Review – 2015

US$ 1500

This report provides comprehensive information on the current therapeutic developmental pipeline of Regeneron Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

06-23 2015   Pages: 86

Lipicard Technologies Limited – Product Pipeline Review – 2015

US$ 1500

This report provides comprehensive information on the current therapeutic developmental pipeline of Lipicard Technologies Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

06-23 2015   Pages: 58

Gilead Sciences, Inc. – Product Pipeline Review – 2015

US$ 1500

This report provides comprehensive information on the current therapeutic developmental pipeline of Gilead Sciences, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

06-23 2015   Pages: 142

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections – Pipeline Review, H1 2015

US$ 2000

This report provides comprehensive information on the therapeutic development for Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),

06-23 2015   Pages: 55

Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) – Pipeline Review, H1 2015

US$ 2000

This report provides comprehensive information on the therapeutic development for Vancomycin Resistant Staphylococcus Aureus Infection (VRSA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),

06-23 2015   Pages: 45

Cardiac Fibrosis – Pipeline Review, H1 2015

US$ 2000

This report provides comprehensive information on the therapeutic development for Cardiac Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates,

06-23 2015   Pages: 67

Cedar Pollen Allergy – Pipeline Review, H1 2015

US$ 2000

This report provides comprehensive information on the therapeutic development for Cedar Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type,

06-23 2015   Pages: 51

Partial Seizure – Pipeline Review, H1 2015

US$ 2000

This report provides comprehensive information on the therapeutic development for Partial Seizure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates,

06-23 2015   Pages: 89

Nephropathy – Pipeline Review, H1 2015

US$ 2000

This report provides comprehensive information on the therapeutic development for Nephropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates,

06-23 2015   Pages: 59
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample